Home
E-Submission
Sitemap
Contact Us
HOME
ABOUT
Aims and scope
About the journal
Editorial board
Principles of transparency and best practice
Management team
Open access
Subscription information
Contact us
BROWSE ARTICLES
All issues
Current issue
Ahead-of print articles
Most read articles
Most download articles
Most cited articles
Search
Author index
FOR AUTHORS AND REVIEWERS
Instructions for authors
Research and publication ethics
Author checklist
E-submission
Submission requirement form
Search
Search
Page Path
HOME
Search
Genetic Testing and Nonsurgical Management for Renal Cell Carcinoma
Original Article
Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma
Dongsu Kim, Bumjin Lim, Jungyo Suh, Dalsan You, Cheryn Song, In Gab Jeong, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn
Journal of Urologic Oncology.
2023;21(2):148-153. Published online July 31, 2023
DOI:
https://doi.org/10.22465/juo.224400400020
Cited By 1
Full text
PubReader
ePub
PDF
1
Journal of
Urologic Oncology
Print ISSN: 2951-603X
Online ISSN: 2982-7043
MOST READ
MOST CITED
4,229
New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
3,913
The Important Role of Poly ADP-Ribose Polymerase Inhibitor in Prostate Cancer
3,537
The Present and Future of Intravesical Therapy in Bladder Cancer
3,153
Trends of First-Line Targeted Therapy in Korean Patients With Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter Study
2,956
Is Cytoreductive Nephrectomy Still Beneficial for Patients With Metastatic Renal Cell Carcinoma in the Contemporary Immunotherapy Era?
+more
Cited By
5
Epidemiology of Urologic Cancer in Korea: Nationwide Trends in the Last 2 Decades
Cited By
2
An Update of Prostate-Specific Membrane Antigen Theranostics in Prostate Cancer
Cited By
2
Complex Epidemiology of Prostate Cancer in Asian Countries
Cited By
2
Prostate Imaging and Reporting and Data System Version 2.1: Limitations for Clinical Use
Cited By
2
Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma
+more